resveratrol has been researched along with Multiple Myeloma in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (50.00) | 29.6817 |
| 2010's | 7 (38.89) | 24.3611 |
| 2020's | 2 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Alkhazali, T; Dang, T; Farhin, R; Park, J; Saade, R; Staskiewicz, A; Tucker, M; Wang, X; Wong, E | 1 |
| Cheng, T; Lai, W; Lu, Y; Ma, R; Peng, Y; Shi, B; Shi, J; Wang, Y; Wu, X; Yang, G; Yi, H; Yu, D | 1 |
| Geng, W; Guo, X; Ji, H; Liu, Z; Ma, Y; Wang, L; Xiong, Y; Zhang, L | 1 |
| Artagan, O; Canturk, Z; Dikmen, M; Ozarda, MG; Ozturk, N | 1 |
| Bhat, AA; Khan, OS; Krishnankutty, R; Mohammad, RM; Uddin, S | 1 |
| Ding, Y; Gao, H; Liao, W; Sun, X; Wang, J; Wang, M; Wang, P; Xu, C; Zhong, Y | 1 |
| Gajate, C; Mollinedo, F; Reis-Sobreiro, M | 1 |
| Kupisiewicz, K | 1 |
| Galson, DL; Ouyang, H; Roodman, GD; Wang, FM | 1 |
| Cavenagh, J; Cook, G; Cook, M; Davies, F; Elliott, P; Gumbleton, T; Jacobson, E; Oakervee, H; Plesner, T; Popat, R | 1 |
| Furusawa, M; Kashimata, M; Nagayama, M; Takeuchi, H; Tanaka, T; Tsuchiya, H | 1 |
| Bonavida, B; Jazirehi, AR | 1 |
| Abdallah, BM; Andersen, TL; Boissy, P; Delaissé, JM; Kassem, M; Plesner, T | 1 |
| Ikeda, Y; Kizaki, M; Nakazato, T; Sagawa, M; Shimizu, T; Xian, MJ | 1 |
| He, W; Hu, Y; Liu, X; Sun, C; Wang, Y; Wei, W; Wu, T | 1 |
| Guo, T; He, WJ; Hu, Y; Sun, CY; Tan, H; Wang, HF; Zhang, XP | 1 |
| Aggarwal, BB; Bhardwaj, A; Bueso-Ramos, C; Gaur, U; Nair, AS; Sethi, G; Shishodia, S; Takada, Y; Vadhan-Raj, S | 1 |
| Chu, ZB; Hong, L; Hu, Y; Huang, J; Sun, CY; Zhang, L | 1 |
2 review(s) available for resveratrol and Multiple Myeloma
| Article | Year |
|---|---|
Therapeutic Potential of Resveratrol in Lymphoid Malignancies.
Topics: Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Humans; Lymphoma; Multiple Myeloma; Resveratrol; Stilbenes | 2016 |
Biological aspects of altered bone remodeling in multiple myeloma and possibilities of pharmacological intervention.
Topics: Antineoplastic Agents, Phytogenic; Bone and Bones; Bone Remodeling; Bone Resorption; Boronic Acids; Bortezomib; Calcium-Binding Proteins; Humans; Intercellular Signaling Peptides and Proteins; Membrane Proteins; Multiple Myeloma; Osteoblasts; Osteoclasts; Protease Inhibitors; Pyrazines; Resveratrol; Signal Transduction; Stilbenes; Wnt Proteins | 2011 |
1 trial(s) available for resveratrol and Multiple Myeloma
| Article | Year |
|---|---|
A phase 2 study of SRT501 (resveratrol) with bortezomib for patients with relapsed and or refractory multiple myeloma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Creatinine; Dehydration; Drug Resistance, Neoplasm; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Multiple Myeloma; Pyrazines; Recurrence; Remission Induction; Resveratrol; Salvage Therapy; Stilbenes; Treatment Failure; Vomiting | 2013 |
15 other study(ies) available for resveratrol and Multiple Myeloma
| Article | Year |
|---|---|
Cytotoxic and Apoptotic Effects of Pinostilbene and Bortezomib Combination Treatment on Human Multiple Myeloma Cells.
Topics: Antineoplastic Agents; Antioxidants; Bortezomib; Caspase 3; Humans; Multiple Myeloma; Resveratrol; Tumor Microenvironment | 2023 |
Resveratrol induces AMPK and mTOR signaling inhibition-mediated autophagy and apoptosis in multiple myeloma cells.
Topics: Adenine; Adenosine Monophosphate; AMP-Activated Protein Kinases; Antineoplastic Agents; Apoptosis; Autophagy; Beclin-1; Caspase 3; Cell Line, Tumor; Cell Survival; Humans; Microtubule-Associated Proteins; Multiple Myeloma; Phosphorylation; Resveratrol; Signal Transduction; TOR Serine-Threonine Kinases | 2021 |
Resveratrol inhibits proliferation, migration and invasion of multiple myeloma cells via NEAT1-mediated Wnt/β-catenin signaling pathway.
Topics: Aged; Cell Line, Tumor; Cell Movement; Cell Proliferation; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Matrix Metalloproteinase 7; Middle Aged; Multiple Myeloma; Neoplasm Invasiveness; Resveratrol; RNA, Long Noncoding; Survivin; Unfolded Protein Response; Wnt Signaling Pathway | 2018 |
Cytotoxic Effects of Resveratrol, Rutin and Rosmarinic Acid on ARH-77 Human (Multiple Myeloma) Cell Line.
Topics: Animals; Antineoplastic Agents, Phytogenic; Artemia; Cell Line, Tumor; Cell Survival; Cinnamates; Depsides; Drug Screening Assays, Antitumor; Humans; Lysosomes; Mitochondria; Multiple Myeloma; Resveratrol; Rosmarinic Acid; Rutin | 2016 |
CSTMP induces apoptosis and mitochondrial dysfunction in human myeloma RPMI8226 cells via CHOP-dependent endoplasmic reticulum stress.
Topics: Apoptosis; Caspases; Cell Line, Tumor; Cell Survival; Cytochromes c; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Humans; Mitochondria; Multiple Myeloma; Pyrazines; Resveratrol; Stilbenes; Transcription Factor CHOP; Unfolded Protein Response | 2016 |
Involvement of mitochondria and recruitment of Fas/CD95 signaling in lipid rafts in resveratrol-mediated antimyeloma and antileukemia actions.
Topics: Antineoplastic Agents; Apoptosis; bcl-X Protein; BH3 Interacting Domain Death Agonist Protein; Boronic Acids; Bortezomib; Caspase 10; Caspase 8; Cell Line, Tumor; Drug Synergism; fas Receptor; Fas-Associated Death Domain Protein; Flow Cytometry; Fluorescent Antibody Technique; Humans; JNK Mitogen-Activated Protein Kinases; Jurkat Cells; Leukemia, T-Cell; Membrane Microdomains; Microscopy, Confocal; Mitochondria; Multiple Myeloma; Phosphorylcholine; Pyrazines; Resveratrol; Signal Transduction; Stilbenes | 2009 |
Resveratrol triggers the pro-apoptotic endoplasmic reticulum stress response and represses pro-survival XBP1 signaling in human multiple myeloma cells.
Topics: Apoptosis; Cell Line, Tumor; Chromatin Immunoprecipitation; DNA-Binding Proteins; DNA, Neoplasm; Drug Screening Assays, Antitumor; Endoplasmic Reticulum; Endoribonucleases; Gene Expression Regulation, Neoplastic; Humans; Multiple Myeloma; Neoplasm Proteins; Phosphorylation; Protein Binding; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Regulatory Factor X Transcription Factors; Resveratrol; RNA Splicing; Signal Transduction; Sirtuin 1; Stilbenes; Transcription Factors; Transcription, Genetic; Unfolded Protein Response; X-Box Binding Protein 1 | 2011 |
Membrane-rigidifying effects of anti-cancer dietary factors.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apigenin; Catechin; Cell Division; Cell Membrane; Diet; Flavonoids; Fluorescence Polarization; Genistein; Isoflavones; Liposomes; Membrane Fluidity; Membrane Lipids; Mice; Multiple Myeloma; Phenols; Resveratrol; Stilbenes; Tumor Cells, Cultured | 2002 |
Resveratrol modifies the expression of apoptotic regulatory proteins and sensitizes non-Hodgkin's lymphoma and multiple myeloma cell lines to paclitaxel-induced apoptosis.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; B-Lymphocytes; bcl-X Protein; Caspases; Cell Cycle; Cell Line, Tumor; DNA-Binding Proteins; Dose-Response Relationship, Drug; Down-Regulation; Drug Interactions; G2 Phase; Humans; Immunoblotting; Intracellular Membranes; Leukocytes, Mononuclear; Lymphoma, Non-Hodgkin; Membrane Potentials; Mitochondria; Models, Biological; Multiple Myeloma; Paclitaxel; Proto-Oncogene Proteins c-bcl-2; Resveratrol; Stilbenes; Time Factors; Transcription Factor AP-1 | 2004 |
Resveratrol inhibits myeloma cell growth, prevents osteoclast formation, and promotes osteoblast differentiation.
Topics: Apoptosis; Calcitriol; Carrier Proteins; Cell Differentiation; Cell Growth Processes; Cell Line, Tumor; Drug Synergism; Gene Expression Regulation, Neoplastic; Humans; Macrophage Colony-Stimulating Factor; Membrane Glycoproteins; Multiple Myeloma; Osteoblasts; Osteocalcin; Osteoclasts; Osteopontin; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Receptors, Calcitriol; Resveratrol; Sialoglycoproteins; Stilbenes | 2005 |
Resveratrol induces apoptosis of human malignant B cells by activation of caspase-3 and p38 MAP kinase pathways.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Caspase 3; Caspases; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Enzyme Activation; Humans; Lymphoma, B-Cell; Multiple Myeloma; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Resveratrol; Stilbenes | 2006 |
Resveratrol downregulates the constitutional activation of nuclear factor-kappaB in multiple myeloma cells, leading to suppression of proliferation and invasion, arrest of cell cycle, and induction of apoptosis.
Topics: Apoptosis; Cell Cycle; Cell Division; Cell Line, Tumor; Cell Nucleus; DNA Replication; Humans; Multiple Myeloma; Neoplasm Invasiveness; NF-kappa B; Resveratrol; Stilbenes | 2006 |
Resveratrol as a novel agent for treatment of multiple myeloma with matrix metalloproteinase inhibitory activity.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein; bcl-X Protein; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Multiple Myeloma; Neoplasm Invasiveness; Plants, Medicinal; Polygonum; Proto-Oncogene Proteins c-bcl-2; Resveratrol; Stilbenes; X-Linked Inhibitor of Apoptosis Protein | 2006 |
Resveratrol inhibits proliferation, induces apoptosis, and overcomes chemoresistance through down-regulation of STAT3 and nuclear factor-kappaB-regulated antiapoptotic and cell survival gene products in human multiple myeloma cells.
Topics: Apoptosis; bcl-2-Associated X Protein; Boronic Acids; Bortezomib; Caspase 3; Cell Proliferation; Cell Survival; Down-Regulation; Drug Resistance, Neoplasm; Enzyme Activation; Gene Expression Regulation, Neoplastic; Humans; Interleukin-6; Multiple Myeloma; NF-kappa B; Proto-Oncogene Proteins c-akt; Pyrazines; Resveratrol; STAT3 Transcription Factor; Stilbenes; Syndecan-1; Thalidomide; Tumor Cells, Cultured | 2007 |
Antimyeloma effects of resveratrol through inhibition of angiogenesis.
Topics: Angiogenesis Inhibitors; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Movement; Cell Proliferation; Fibroblast Growth Factor 2; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Multiple Myeloma; Resveratrol; RNA, Messenger; Stilbenes; Vascular Endothelial Growth Factor A | 2007 |